IDSA Issues Vaccine Recommendations for 2026-2027
New clinical recommendations emphasize the safety and importance of COVID-19, influenza, and RSV vaccines for individuals with weakened immune systems.
New clinical recommendations emphasize the safety and importance of COVID-19, influenza, and RSV vaccines for individuals with weakened immune systems.
New clinical recommendations emphasize the safety and importance of COVID-19, influenza, and RSV vaccines for individuals with weakened immune systems.
Read MoreUpdated formulas from Pfizer, Moderna, and Novavax target the circulating XFG variant for older adults and high-risk populations.
Read MoreCVS and Walgreens are expanding walk-in access, multi-vaccine scheduling, and respiratory illness testing ahead of peak viral activity.
Read MorePresident Donald Trump signed an executive order on Monday that revises federal recommendations for the childhood vaccination schedule, according to multiple media reports including the AP.
Read MoreResearchers found that five core values—safety, knowledge, trust, humanity, and autonomy—shape how minority parents approach pediatric vaccination.
Read MoreAn NFID initiative provided evidence-based guidance on influenza, COVID-19, and RSV during the 2025-2026 season.
Read MoreA survey of frontline healthcare workers suggests a protein-based COVID-19 vaccine may cause fewer symptoms and less work disruption compared to mRNA options.
Read MoreA US district court blocked HHS Secretary Robert Kennedy Jr’s recent moves to revise the federal childhood vaccine schedule and overhaul of the CDC’s vaccine advisory board, according to multiple media reports including Reuters.
Read MoreParticipants with no prior exposure to SARS-CoV-2 experienced fewer vaccine side effects and continued increases in antibody levels over six months.
Read MoreNew research suggests that messier, less-stuffed nanoparticles may actually deliver drugs more effectively than tightly packed ones.
Read MoreVirus-like systems safely replicate key features of pathogens like SARS-CoV-2, enabling faster vaccine and antiviral testing in standard biosafety level 2 labs.
Read MoreBooster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million UK adults who had the autumn 2022 vaccine.
Read MoreCOVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia.
Read MoreScientists have identified why some patients developed dangerous blood clots called vaccine-induced immune thrombocytopenia and thrombosis (VITT) after receiving certain COVID‑19 vaccines, or after natural adenovirus infection.
Read MoreVaccination against influenza and COVID-19 currently lags among people 50 and older, according to a national survey.
Read MoreThe 2026 AAP recommendations remain largely unchanged from 2025 but differ from the CDC’s new immunization schedule.
Read MoreThe CDC and HHS reduced the federally recommended childhood immunization schedule from 17 to 11 vaccinations, removing shots for seasonal flu and other infectious diseases.
Read MoreThe mRNA and lipid nanoparticles that deliver it actively stimulate the immune system and work together to produce germinal centers and immune protection.
Read MoreCOVID-19 vaccinated children had significantly fewer infections, including pneumonia, bronchitis, bronchiolitis, sinusitis, upper respiratory infections, and more.
Read MoreCommercially available mRNA COVID-19 vaccines can train patients’ immune systems to eliminate cancer, according to data presented at ESMO 2025.
Read MoreCOVID-19 vaccination is associated with better neonatal outcomes without added maternal risk, according to an analysis of data from over 1.2 million pregnancies.
Read MoreThe US CDC’s Advisory Committee on Immunization Practices (ACIP) issued guidance on COVID-19 vaccination recommending “shared clinical decision-making.”
Read MorePreliminary data show the Comirnaty COVID-19 vaccine increases neutralizing antibodies targeting the LP.8.1 sublineage of SARS-CoV-2.
Read MorePolitical polarization during COVID-19 was 12 times greater than in past disease outbreaks in terms of vaccine hesitancy.
Read More